Pharmaceuticals by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Grifols has the lowest figure of the 50 pharmaceuticals ranked by P/S ratio, at 0.7, followed by Viatris (1.6) and GSK (2.3). Figures as of 18 Nov 2026, 14:08 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 50
- Lowest
- Grifols0.7
- Median
- 7.0
- Combined market value
- THB 175.07T
- Countries
- 10
- Not ranked
- 11no P/S ratio on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | GrifolsGRFS · Health Care | 0.7 | THB 199.3B | THB 292.90 | 1.15% down | 1% up | ||
| 2 | ViatrisVTRS · Health Care | 1.6 | THB 795.7B | THB 694.07 | 1.40% down | 96% up | ||
| 3 | GSKGSK · Health Care | 2.3 | THB 3.35T | THB 1,671.21 | 2.32% down | 6% up | ||
| 4 | SanofiSNY · Health Care | 2.4 | THB 3.87T | THB 1,613.17 | 1.78% down | 4% down | ||
| 5 | Amneal PharmaceuticalsAMRX · Health Care | 2.4 | THB 249.7B | THB 716.81 | 0.52% down | 83% up | ||
| 6 | Takeda PharmaceuticalTAK · Health Care | 2.5 | THB 2.35T | THB 734.46 | 0.23% up | 54% up | ||
| 7 | PfizerPFE · Health Care | 2.6 | THB 5.51T | THB 966.27 | 1.35% down | 14% up | ||
| 8 | Bristol-Myers SquibbBMY · Health Care | 2.6 | THB 4.26T | THB 2,082.22 | 2.51% down | 34% up | ||
| 9 | Elanco Animal HealthELAN · Health Care | 2.7 | THB 438.5B | THB 877.35 | 2.12% down | 20% up | ||
| 10 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.9 | THB 1.69T | THB 1,446.52 | 0.12% up | 74% up | ||
| 11 | PTC TherapeuticsPTCT · Health Care | 2.9 | THB 171.2B | THB 2,048.62 | 1.00% down | 20% down | ||
| 12 | Legend BiotechLEGN · Health Care | 3.0 | THB 106.1B | THB 546.77 | 0.75% up | 42% down | ||
| 13 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.4 | THB 418.5B | THB 501.97 | 0.61% up | 5% up | ||
| 14 | BioMarin PharmaceuticalBMRN · Health Care | 3.5 | THB 384.6B | THB 1,985.83 | 0.90% up | 11% up | ||
| 15 | ZoetisZTS · Health Care | 3.6 | THB 1.15T | THB 2,833.31 | 1.08% down | 29% down | ||
| 16 | Jazz PharmaceuticalsJAZZ · Health Care | 3.6 | THB 524.4B | THB 8,169.70 | 0.39% up | 37% up | ||
| 17 | Novo NordiskNVO · Health Care | 3.9 | THB 6.09T | THB 1,381.36 | 2.16% down | 17% down | ||
| 18 | Abbott LaboratoriesABT · Health Care | 4.1 | THB 6.16T | THB 3,553.86 | 2.55% down | 17% down | ||
| 19 | Ionis PharmaceuticalsIONS · Health Care | 4.8 | THB 152.4B | THB 915.02 | 3.75% down | 64% down | ||
| 20 | AstraZenecaAZN · Health Care | 4.8 | THB 9.59T | THB 6,186.24 | 0.95% down | 2% up | ||
| 21 | AlkermesALKS · Health Care | 5.2 | THB 259.2B | THB 1,542.57 | 2.32% down | 58% up | ||
| 22 | Merck & CoMRK · Health Care | 5.4 | THB 12T | THB 4,865.98 | 0.75% down | 51% up | ||
| 23 | NovartisNVS · Health Care | 5.5 | THB 10.2T | THB 5,400.87 | 0.67% down | 25% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | 5.6 | THB 711.4B | THB 5,311.61 | 2.02% down | 66% down | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | 6.9 | THB 3.36T | THB 32,506.37 | 0.56% up | 36% up | ||
| 26 | Johnson & JohnsonJNJ · Health Care | 7.1 | THB 22.77T | THB 9,459.08 | 1.36% down | 38% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | 7.3 | THB 206.3B | THB 1,459.08 | 2.76% down | 10% up | ||
| 28 | United TherapeuticsUTHR · Health Care | 7.8 | THB 844.3B | THB 19,824.35 | 0.64% down | 23% up | ||
| 29 | AbbVieABBV · Health Care | 8.5 | THB 17.57T | THB 9,938.31 | 0.59% down | 26% up | ||
| 30 | GenmabGMAB · Health Care | 8.6 | THB 1.09T | THB 1,763.52 | 0.76% up | 70% up | ||
| 31 | BeOne MedicinesONC · Health Care | 8.8 | THB 1.6T | THB 14,026.04 | 0.48% up | 17% up | ||
| 32 | Travere TherapeuticsTVTX · Health Care | 10.0 | THB 166.5B | THB 1,734.33 | 2.82% up | 44% up | ||
| 33 | Corcept TherapeuticsCORT · Health Care | 10.1 | THB 260.3B | THB 2,378.18 | 1.23% up | 8% down | ||
| 34 | Madrigal PharmaceuticalsMDGL · Health Care | 10.2 | THB 332.7B | THB 14,322.34 | 0.46% down | 24% down | ||
| 35 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.0 | THB 253.6B | THB 3,228.03 | 0.93% up | 126% up | ||
| 36 | Axsome TherapeuticsAXSM · Health Care | 11.2 | THB 242.7B | THB 4,614.14 | 0.77% down | 7% down | ||
| 37 | Vertex PharmaceuticalsVRTX · Health Care | 11.3 | THB 4.6T | THB 18,130.75 | 0.67% down | 27% up | ||
| 38 | Mirum PharmaceuticalsMIRM · Health Care | 11.5 | THB 203.7B | THB 3,120.78 | 0.40% up | 31% up | ||
| 39 | TG TherapeuticsTGTX · Health Care | 15.4 | THB 321.7B | THB 2,128.38 | 0.08% down | 107% up | ||
| 40 | Royalty PharmaRPRX · Health Care | 16.6 | THB 1.34T | THB 2,331.00 | 0.23% up | 78% up | ||
| 41 | Eli LillyLLY · Health Care | 19.3 | THB 42.79T | THB 48,043.77 | 1.13% down | 35% up | ||
| 42 | Ligand PharmaceuticalsLGND · Health Care | 21.9 | THB 199.5B | THB 9,971.91 | 2.62% down | 43% up | ||
| 43 | Ascendis PharmaASND · Health Care | 22.3 | THB 603.8B | THB 9,204.19 | 0.20% down | 28% up | ||
| 44 | BridgeBio PharmaBBIO · Health Care | 29.8 | THB 507.8B | THB 2,606.59 | 0.72% down | 17% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | 42.6 | THB 274.4B | THB 3,957.74 | 8.49% up | 13% up | ||
| 46 | InsmedINSM · Health Care | 44.1 | THB 907.3B | THB 4,135.93 | 0.83% down | 40% down | ||
| 47 | CytokineticsCYTK · Health Care | 81.7 | THB 244.2B | THB 1,753.00 | 2.86% down | 20% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | 177 | THB 276.2B | THB 4,231.30 | 0.13% down | 46% up | ||
| 49 | Dianthus TherapeuticsDNTH · Health Care | 2406 | THB 166.2B | THB 2,952.10 | 2.87% down | 113% up | ||
| 50 | Roivant SciencesROIV · Health Care | 3396 | THB 951.9B | THB 1,313.82 | 0.26% up | 90% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 33.9400 THB). 11 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which pharmaceuticals have the lowest P/S ratio?
Grifols (0.7), Viatris (1.6) and GSK (2.3) have the lowest P/S ratio of the 50 pharmaceuticals ranked here as of 18 Nov 2026, 14:08 UTC.
How many pharmaceuticals are in this ranking?
50 are ranked by P/S ratio. 11 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these pharmaceuticals worth together?
The 50 pharmaceuticals ranked by P/S ratio have a combined market value of THB 175.07T as of 18 Nov 2026, 14:08 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.